greenmellen

/Green Mellen

About Green Mellen

This author has not yet filled in any details.
So far Green Mellen has created 85 blog entries.

Intellectual Property Partner, Micah Stolowitz, will be speaking at The BigML Event, “The Importance of Protecting Your Inventions on Time; From a startup, a big corporation, and a legal perspective”, in Spain on October 25-27, 2017

Click here for more info

Client Alert – Guilty Pleas Continue to Amass in New Jersey State Health Benefits Fraud Investigation

October 12, 2017 - In late summer we issued a client alert describing a healthcare fraud scheme that had hit two New Jersey state health benefits programs for over $25 million by submitting fraudulent prescriptions for compounded medications. At the time of the initial alert, five conspirators had submitted guilty pleas to an assortment of [...]

Client Alert – Insys Therapeutics Runs Afoul of Attorneys General in Two States

October 10, 2017 - Arizona-based pharmaceutical company Insys Therapeutics Inc. (Insys) has found itself under investigation in both Massachusetts and New Jersey over the aggressive marketing of its opioid-fentanyl drug Subsys. Subsys has been approved by the FDA for use with breakthrough pain in cancer patients who have developed tolerance to other opioid-based drugs. The [...]

Client Alert – Diagnostic Test Maker Alere Faces Whistleblower FCA Suit

October 9, 2017 - A recently unsealed suit against Alere Inc., initially filed by two whistleblowers in a Florida federal court in 2015, reveals multiple allegations of False Claims Act (FCA) and Anti-Kickback Statute violations against the diagnostic test-maker. The whistleblowers, former Alere vice president of business development Michael Nolan and Jacob Whitfield, a former [...]

Client Alert – AmerisourceBergen Agrees to Pay $260 Million for Mislabling Oncology Drugs

October 3, 2017 - Late last week drug wholesaler AmerisourceBergen Corp (ASBG) pleaded guilty in federal court in Brooklyn to violations of the federal Food, Drug and Cosmetic Act. ASBG disclosed in a stipulated statement of facts at the hearing that a former ASBG business unit, the Alabama-based company Medical Initiatives Inc., (MII) had sold [...]

Corporate Law Update – New Federal Overtime Rules Are Gone For Now – What’s Next?

On August 31, 2017, a federal district court in Texas granted summary judgment in favor of fifty-five business groups and twenty-one states that sought to enjoin Obama-era changes to overtime pay rules.  Those changes would have more than doubled a salary level threshold for common “white collar” overtime exemption categories and impacted an estimated 4.2 [...]

Employment and Litigation Partner Amy Epstein Gluck Quoted in Washington Post Magazine

Employment and Litigation Partner Amy Epstein Gluck quoted by Washington Post Magazine @workadvice columnist Karla Miller about the perils of employing an individual who promotes racist or anti-Semitic views at work or outside of the workplace To read full article, click here.

CVS Health Named in Insulin Price Fixing Investigations; Class Action Suits also Pending

October 2, 2017 - In a recent SEC filing, CVS Health (CVS) has disclosed just how embroiled its PBM division has become in a number of insulin price fixing investigations and lawsuits nationwide. Two putative class action suits have been filed against CVS, along with a number of other PBMs and drug manufacturers, in the [...]

Intellectual Property Law Update: September 2017

Fall: time for baseball playoffs, NFL season in high gear … and IP-related profit opportunities such as: Considerations when addressing requests for assumption of IP licenses by bankrupt companies; Ramifications of US Supreme Court case allowing ‘disparaging’ trademarks; How a Privacy Shield filing can help you meet your GDPR obligations; Uber and privacy policies!! Your [...]

Litigation and Employment Partner Richard Cohen will be speaking on September 27th at the 29th Annual General Counsel Conference in New York about “Significant Developments in the Workers Rights Landscape”

Click here for more info.